Cris Loiren Rodriguez

Array ( [id] => 8063719 [patent_doc_number] => 20110245165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'PEPTIDE AGONISTS OF GLP-1 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/770667 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29011 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245165.pdf [firstpage_image] =>[orig_patent_app_number] => 12770667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15753737 [patent_doc_number] => 10618964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-14 [patent_title] => Nanobody against IL-6R [patent_app_type] => utility [patent_app_number] => 13/263223 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 165921 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262668 [patent_doc_number] => 20100297127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'USE OF IL-27 ANTAGONISTS TO TREAT LUPUS' [patent_app_type] => utility [patent_app_number] => 12/756871 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 54139 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297127.pdf [firstpage_image] =>[orig_patent_app_number] => 12756871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234891 [patent_doc_number] => 20100266595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'TREATMENT OF INSULIN-RESISTANT DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/749876 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18563 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266595.pdf [firstpage_image] =>[orig_patent_app_number] => 12749876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16414515 [patent_doc_number] => 10822391 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Fusion proteins and methods for inhibiting IL-17 pathways [patent_app_type] => utility [patent_app_number] => 12/731772 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 18458 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12731772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978444 [patent_doc_number] => 20110071277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'RESISTIN ANTAGONISTS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/722950 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10061 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071277.pdf [firstpage_image] =>[orig_patent_app_number] => 12722950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6550540 [patent_doc_number] => 20100233186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'NOVEL RECEPTOR THAT BINDS CTLA-8' [patent_app_type] => utility [patent_app_number] => 12/722477 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8091 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233186.pdf [firstpage_image] =>[orig_patent_app_number] => 12722477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171240 [patent_doc_number] => 20120107267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'INTERLEUKIN-21 VARIANTS HAVING ANTAGONISTIC BINDING TO THE IL-21 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/147292 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13817 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107267.pdf [firstpage_image] =>[orig_patent_app_number] => 13147292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087772 [patent_doc_number] => 20110217259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'IL-16 as a target for diagnosis and therapy of hematological malignancies and solid tumors' [patent_app_type] => utility [patent_app_number] => 12/716481 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7560 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217259.pdf [firstpage_image] =>[orig_patent_app_number] => 12716481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6460052 [patent_doc_number] => 20100190211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'IL-18 Receptors' [patent_app_type] => utility [patent_app_number] => 12/716993 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12778 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190211.pdf [firstpage_image] =>[orig_patent_app_number] => 12716993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289836 [patent_doc_number] => 20100158897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'PAI-1 MODULATORS FOR THE TREATMENT OF OCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/716137 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5755 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158897.pdf [firstpage_image] =>[orig_patent_app_number] => 12716137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270354 [patent_doc_number] => 20100254941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'INTERLEUKIN-18 BINDING PROTEINS, THEIR PREPARATION AND USE FOR THE TREATMENT OF SEPSIS' [patent_app_type] => utility [patent_app_number] => 12/715089 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 38243 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254941.pdf [firstpage_image] =>[orig_patent_app_number] => 12715089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6443721 [patent_doc_number] => 20100144605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'RESCUE OF GONADOTROPIN RELEASING HORMONE RECEPTOR MUTANTS' [patent_app_type] => utility [patent_app_number] => 12/702128 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11412 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144605.pdf [firstpage_image] =>[orig_patent_app_number] => 12702128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662206 [patent_doc_number] => 20110311475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'MEANS AND METHOD FOR THE TREATMENT OF ANTIBODY DEFICIENCY DISEASES BASED ON IL-21 AND IL-21 VARIANTS' [patent_app_type] => utility [patent_app_number] => 13/143235 [patent_app_country] => US [patent_app_date] => 2010-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 58545 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311475.pdf [firstpage_image] =>[orig_patent_app_number] => 13143235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245224 [patent_doc_number] => 20100135901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 12/637109 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23194 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20100135901.pdf [firstpage_image] =>[orig_patent_app_number] => 12637109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776202 [patent_doc_number] => 20120039840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'Use of IL-27-P28 to antagonize IL-6 mediated signaling' [patent_app_type] => utility [patent_app_number] => 12/998799 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26557 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039840.pdf [firstpage_image] =>[orig_patent_app_number] => 12998799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6437147 [patent_doc_number] => 20100143973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Interleukin-11 Fusion Proteins' [patent_app_type] => utility [patent_app_number] => 12/626107 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22364 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143973.pdf [firstpage_image] =>[orig_patent_app_number] => 12626107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066269 [patent_doc_number] => 20110243888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'IL-29 MUTANTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/129042 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31858 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243888.pdf [firstpage_image] =>[orig_patent_app_number] => 13129042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6429640 [patent_doc_number] => 20100143246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Interleukin 17 Receptor-Like Protein' [patent_app_type] => utility [patent_app_number] => 12/618178 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 112712 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143246.pdf [firstpage_image] =>[orig_patent_app_number] => 12618178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5984589 [patent_doc_number] => 20110097331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/617078 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 38515 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097331.pdf [firstpage_image] =>[orig_patent_app_number] => 12617078 [rel_patent_id] =>[rel_patent_doc_number] =>)